Literature DB >> 18560331

A convenient synthesis of amino acid methyl esters.

Jiabo Li1, Yaowu Sha.   

Abstract

A series of amino acid methyl ester hydrochlorides were prepared in good to excellent yields by the room temperature reaction of amino acids with methanol in the presence of trimethylchlorosilane. This method is not only compatible with natural amino acids, but also with other aromatic and aliphatic amino acids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560331      PMCID: PMC6245331          DOI: 10.3390/molecules13051111

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


Introduction

Amino acid methyl esters are important intermediates in organic synthesis, which have been used in various areas such as peptide synthesis [1], medicinal chemistry [2,3], as chiral sources [4,5,6,7] and polymer materials [8,9]. A variety of reagents have been reported for the transformation of amino acids into amino acid methyl esters, which include protic acids (gaseous hydrochloric acid [10], sulfuric acid and p-toluene- sulfonic acid), thionyl chloride [11], 2,2-dimethoxypropane [12] and ion-exchange resins (Amberlyst™-15, [13]). There are other methods which require multistep reactions to obtain the products, such as the sequence of N-protection, esterification and deprotection. Although some of them are widely used, they still have several disadvantages, including tedious workup procedures, safety and waste disposal problems and harsh reaction conditions. Methanol/trimethylchlorosilane has been shown to be a convenient system for the preparation of methyl esters of various carboxylic acids [14, 15]. This method has been used in the transformation of N-Boc-α-amino acids into N-unprotected α-amino methyl esters [16] and some other amino acid methyl esters have been prepared using this system [17,18,19,20]. In order to demonstrate the general applicability of the method, we have examined a series of amino acids as substrates, including natural, aromatic and aliphatic amino acids and in this communication we report that trimethylchlorosilane (TMSCl) with methanol at room temperature is an efficient reagent for esterification of amino acids of all classes. Compared to the methods mentioned above the use of TMSCl/MeOH was more advantageous due to the following features: easy operation, mild reaction conditions, simple workup and good to excellent yields.

Results and Discussion

The synthesis of acid methyl ester hydrochlorides is shown in Scheme 1. A series of amino acids, including natural amino acids, aromatic amino acids and aliphatic amino acids was transformed to corresponding amino acid methyl ester hydrochlorides in good to excellent yields, which are summarized in Table 1.
Scheme 1
Table 1

Esterification of amino acids witd metdanol in tde presence of TMSCl.

EntrySubstrateProduct aTime (hr)bYield (%) cReported yields (%) d
1 249689 [21]
2 248998 [22]
3 129797 [23]
4 129695 [23]
5 128897 [24]
6 129688 [25]
7 128565 [26]
8 127629 [27]
9 129192 [28]
10 129493 [29]
11 128971 [30]
12 1286100 [31]
13 248672 [32]
14 249078 [33]
15 129699 [35]
16 128693 [36]
17 129493 [36]
18 129892 [37]
19 249762 [38]

a All products are isolated as hydrochloride salts.

b Reaction times are not optimized

c All yields refer to isolated products, fully characterized by 1H- and 13C-NMR and MS.

d The yields of entries 1, 2, 9, 15,16, 17 were with the thionyl chloride/MeOH system, entry 13 in H2SO4/MeOH system, and the remainder with the HCl/MeOH system.

Compared with other methods, the yields obtained with the TMSCl/MeOH system were in most cases comparable to or even higher than those obtained with the thionyl chloride/MeOH and HCl(SO4H2)/MeOH systems and the method is certainly more convenient from an operational point of view. For example, for best results the temperature of the thionyl chloride/MeOH system should be strictly maintained between –5~0 ˚C and HCl gas must be continuously passed through the refluxing mixture in the MeOH/HCl method, making the TMSCl/MeOH system obviously more convenient. In general, two equivalents of TMSCl were used. However, the substrates in entries 2, 12 and 18 have two carboxyl groups, so four equivalents of TMSCl were used in the esterifications of these substrates. In general the reaction time was 12 h. Because of the poor solubility in methanol of both of substrates and products in entries 1, 2, 13, 14, 19, the reaction time for these substrates was 24 h. Racemization is a common problem in the synthesis of amino acid esters. According to a published report esterification of protected amino acids by TMSCl showed little racemization [16]. It would of course be more interesting if free amino acids could be directly esterified with little racemization and work to determine if this is possible is currently under way in our lab and the results will be reported in due course. Esterification of amino acids witd metdanol in tde presence of TMSCl. a All products are isolated as hydrochloride salts. b Reaction times are not optimized c All yields refer to isolated products, fully characterized by 1H- and 13C-NMR and MS. d The yields of entries 1, 2, 9, 15,16, 17 were with the thionyl chloride/MeOH system, entry 13 in H2SO4/MeOH system, and the remainder with the HCl/MeOH system.

Conclusions

We have developed a facile method to synthesize different amino acid methyl ester hydrochlorides through the esterification of corresponding amino acids with methanol using trimethylchlorosilane. The reaction offers convenience, mild conditions and good to excellent yields.

Experimental

General

1H-NMR (300 MHz) and 13C-NMR (75 MHz) spectra were recorded in D2O on a JEOL JNM-ECA300 spectrometer. All ESI-MS experiments were done on a Bruker ESQUIRE-LC.

General procedure for the preparation of amino acid methyl ester hydrochlorides

Amino acid (0.1 mol) was taken in a round bottom flask. Freshly distilled chlorotrimethylsilane (0.2 mol) was added slowly and stirred with a magnetic stirrer. Then methanol (100 mL) was added and the resulting solution or suspension was stirred at room temperature. After the completion of reaction (as monitored by TLC), the reaction mixture was concentrated on a rotary evaporator to give the product amino acid ester hydrochloride. Glycine methyl ester (entry 1). 1H-NMR: δ 4.03 (s, 2H), 3.92 (s, 3H); 13C-NMR: δ 168.8, 53.5, 40.2; ESI-MS: calcd. for (M+H)/z: 90.1, found: (M+H)/z: 90.1. Dimethyl iminodiacetate (entry 2). 1H-NMR: δ 4.06 (s, 4H), δ 3.77 (s, 6H); 13C-NMR: δ 167.5, 53.6, 47.2; ESI-MS: calcd. for (M+H)/z: 162.1, found: (M+H)/z: 162.3. α -Alanine methyl ester (entry 3). 1H-NMR: δ 4.14 (m, 1H), 3.76 (s, 3H), 1.49 (m, 3H); 13C-NMR: δ 171.3, 53.7, 48.9, 15.2; ESI-MS: calcd. for (M+H)/z: 104.0, found: (M+H)/z: 104.1. Leucine methyl ester (entry 4). 1H-NMR: δ 4.10 (t, 1H), 3.78 (s, 3H), 1.82 (m, 1H), 1.65 (m, 2H), 0.89 (m, 6H); 13C-NMR: δ 171.4, 53.6, 51.6, 38.9, 24.0, 21.6, 21.2; ESI-MS: calcd. for (M+H)/z: 146.0, Found:(M+H)/z: 146.3. 6-Aminocaproic acid methyl ester (entry 5). 1H-NMR: δ 3.62 (s, 3H), 2.93 (t, 2H), 2.35 (t, 2H), 1.61-1.55 (m, 4H), 1.33 (m, 2H); 13C-NMR: δ 177.4, 52.3, 39.4, 33.5, 26.5, 25.2, 23.8; ESI-MS: calcd. for (M+H)/z: 146.1, found: (M+H)/z: 146.1. Phenylalanine methyl ester (entry 6). 1H-NMR: δ 7.37-7.34 (m, 3H), 7.23 (d, 1H), 7.21 (d, 1H), 4.36 (t, 1H), 3.77 (s, 3H), 3.29-3.13 (m, 2H); 13C-NMR: δ 170.1, 133.8, 129.5, 128.2, 54.2, 53.7, 35.7; ESI-MS: calcd. for (M+H)/z: 180.1, found: (M+H)/z: 180.1. Methionine methyl ester (entry 7). 1H-NMR: δ 4.51 (t, 1H), 3.79 (s, 3H), 3.30 (d, 2H); 13C-NMR: δ 169.2, 54.0, 51.6, 35.7; ESI-MS: calcd. for (M+H)/z: 139.0, found: (M+H)/z: 139.2. Proline methyl ester (entry 8). 1H-NMR: δ 4.39 (m, 1H), 3.76 (s, 3H), 2.35 (m, 2H), 2.03 (m, 2H), 1.98 (m, 2H); 13C-NMR: δ 170.5, 59.7, 53.9, 46.4, 28.4, 23.4; ESI-MS: calcd. for (M+H)/z: 130.0, found: (M+H)/z: 130.1. Tryptophan methyl ester (entry 9). 1H-NMR: δ 7.42 (d, 1H), 7.39 (d, 1H), 7.16 (d, 1H), 7.14 (d, 1H), 7.04 (t, 1H), 4.24 (t, 1H), 3.66 (s, 3H), 3.25 (m, 2H); 13C-NMR: δ 170.4, 136.4, 126.5, 125.4, 122.3, 119.6, 118.1, 112.1, 106.0, 53.7, 53.4, 25.7; ESI-MS: calcd. for (M+H)/z: 219.1, found: (M+H)/z: 219.2. Lysine methyl ester (entry 10). 1H-NMR: δ 4.12 (t, 1H), 3.79 (s, 3H), 2.97 (t, 2H), 1.94 (m, 2H), 1.67 (m, 2H), 1.46 (m, 2H); 13C-NMR: δ 170.7, 53.7, 52.9, 39.2, 29.4, 26.4, 21.6; ESI-MS: calcd. for (M+H)/z: 161.1, found: (M+H)/z: 161.0. Arginine methyl ester (entry 11). 1H-NMR: δ 4.14 (t, 1H), 3.78 (s, 3H), 3.20 (m, 2H), 1.95 (m, 2H), 1.67 (m, 2H); 13C NMR: δ 170.5, 156.9, 53.8, 52.6, 40.4, 27.0, 23.9; ESI-MS: calcd. for (M+H)/z: 189.1, found: (M+H)/z: 189.1. Aspartic acid dimethyl ester (entry 12). 1H-NMR: δ 4.44 (dd, 1H), 3.77 (s, 3H), 3.68 (s, 3H), 3.10 (dd, 2H); 13C-NMR: δ 171.7, 169.4, 54.0, 53.1, 49.3, 33.7; ESI-MS: calcd. for (M+H)/z: 162.0, found: (M+H)/z: 162.1. Methyl 4-aminobenzoate (entry 13). 1H-NMR: δ 7.86 (d, 1H), 7.83 (d, 1H), 7.32 (d, 1H), 7.29 (d, 1H), 3.72(s, 3H); 13C-NMR: δ 167.9, 135.2, 131.2, 129.6, 123.0, 52.8; ESI-MS: calcd. for (M+H)/z: 152.1, found: (M+H)/z: 152.2. Methyl 3-aminobenzoate (entry 14). 1H-NMR: δ 7.90-7.83 (m, 2H), 7.51 (m, 2H), 3.77 (s, 3H); 13C- NMR: δ 167.6, 131.4, 130.6, 130.2, 130.1, 128.0, 123.9, 53.0; ESI-MS: calcd. for (M+H)/z: 152.0, found: (M+H)/z: 152.1. β-Alanine methyl ester (entry 15). 1H-NMR: δ 3.68 (s, 3H), 3.22 (t, 2H), 2.77 (t, 2H); 13C-NMR: δ 173.2, 52.7, 35.2, 31.2; ESI-MS: calcd. for (M+H)/z: 104.0, found: (M+H)/z: 104.1. γ-Aminobutyric methyl ester (entry 16). 1H-NMR: δ 3.63 (s, 3H), 2.97 (t, 3H), 2.45(m, 2H), 1.89 (t, 2H); 13C-NMR: δ 175.7, 52.4, 38.8, 30.6, 22.1; ESI-MS: calcd. for (M+H)/z: 118.2, found: (M+H)/z: 118.3. Methyl 4-(aminomethyl)cyclohexanecarboxylate (entry 17). 1H-NMR: δ 3.59 (s, 3H), 2.79 (m, 2H), 2.29 (m, 1H), 1.94-1.90 (m, 2H), 1.78-1.75 (m, 2H), 1.57 (m, 1H), 1.38-1.26 (m, 2H), 1.04-0.92 (m, 2H); 13C-NMR: δ 179.4, 52.3, 44.9, 42.6, 34.8, 28.5, 27.7; ESI-MS: calcd. for (M+H)/z: 172.1, found: (M+H)/z: 172.2. Cystine dimethyl ester (entry 18). 1H-NMR: δ 4.50 (t, 1H), 3.79 (s, 3H), 3.37-3.25(m, 2H); 13C-NMR: δ 169.2, 54.0, 51.6, 35.7; ESI-MS: calcd. for (M+H)/z: 269.0, found: (M+H)/z: 269.0. Methyl 4-(aminomethyl)benzoate (entry 19). 1H-NMR: δ 7.96 (d, 2H), 7.64 (d, 2H), 4.08(s, 2H), 3.84 (s, 3H); 13C-NMR: δ 166.0, 147.8, 130.0, 128.3, 126.6, 51.5, 45.5; ESI-MS: calcd. for (M+H)/z: 166.0, found: (M+H)/z: 166.1.
  14 in total

1.  Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.

Authors:  Vishnu K Tandon; Dharmendra B Yadav; Ravindra V Singh; Ashok K Chaturvedi; Praveen K Shukla
Journal:  Bioorg Med Chem Lett       Date:  2005-10-03       Impact factor: 2.823

2.  On the use of trimethylchlorosilane in methanol for methylation of thyroxine prior to perfluoroacylation and isotope dilution-gas chromatography/mass spectrometry.

Authors:  V I De Brabandere; D Stöckl; L M Thienpont; A P De Leenheer
Journal:  J Mass Spectrom       Date:  1998-10       Impact factor: 1.982

3.  Analogues of thiolactomycin as potential antimalarial agents.

Authors:  Simon M Jones; Jonathan E Urch; Marcel Kaiser; Reto Brun; John L Harwood; Colin Berry; Ian H Gilbert
Journal:  J Med Chem       Date:  2005-09-22       Impact factor: 7.446

4.  5-benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity.

Authors:  Caterina Carmi; Andrea Cavazzoni; Valentina Zuliani; Alessio Lodola; Fabrizio Bordi; Pier Vincenzo Plazzi; Roberta R Alfieri; Pier Giorgio Petronini; Marco Mor
Journal:  Bioorg Med Chem Lett       Date:  2006-05-19       Impact factor: 2.823

5.  Preparation and Use of Aziridino Alcohols as Promoters for the Enantioselective Addition of Dialkylzinc Reagents to N-(Diphenylphosphinoyl) Imines.

Authors:  Pher G. Andersson; David Guijarro; David Tanner
Journal:  J Org Chem       Date:  1997-10-17       Impact factor: 4.354

6.  Evaluation of azasterols as anti-parasitics.

Authors:  Ludovic Gros; Silvia Orenes Lorente; Carmen Jimenez Jimenez; Vanessa Yardley; Lauren Rattray; Hayley Wharton; Susan Little; Simon L Croft; Luis M Ruiz-Perez; Dolores Gonzalez-Pacanowska; Ian H Gilbert
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

7.  Synthesis of analogues of Congo red and evaluation of their anti-prion activity.

Authors:  Shane Sellarajah; Tamuna Lekishvili; Claire Bowring; Andrew R Thompsett; Helene Rudyk; Christopher R Birkett; David R Brown; Ian H Gilbert
Journal:  J Med Chem       Date:  2004-10-21       Impact factor: 7.446

8.  Enantioselective cyclization of racemic supramolecular polymers.

Authors:  A Tessa ten Cate; Patricia Y W Dankers; Huub Kooijman; Anthony L Spek; Rint P Sijbesma; E W Meijer
Journal:  J Am Chem Soc       Date:  2003-06-11       Impact factor: 15.419

9.  Synthesis and activity of 5'-uridinyl dipeptide analogues mimicking the amino terminal peptide chain of nucleoside antibiotic mureidomycin A.

Authors:  Nigel I Howard; Timothy D H Bugg
Journal:  Bioorg Med Chem       Date:  2003-07-17       Impact factor: 3.641

10.  Aspartyl phosphonates and phosphoramidates: the first synthetic inhibitors of bacterial aspartate-semialdehyde dehydrogenase.

Authors:  Russell J Cox; Jennifer S Gibson; María Belén Mayo Martín
Journal:  Chembiochem       Date:  2002-09-02       Impact factor: 3.164

View more
  19 in total

1.  Synthesis of β-Peptide Standards for Use in Model Prebiotic Reactions.

Authors:  Jay G Forsythe; Sloane L English; Rachel E Simoneaux; Arthur L Weber
Journal:  Orig Life Evol Biosph       Date:  2018-05-23       Impact factor: 1.950

2.  Unstable reaction intermediates and hysteresis during the catalytic cycle of 5-aminolevulinate synthase: implications from using pseudo and alternate substrates and a promiscuous enzyme variant.

Authors:  Bosko M Stojanovski; Gregory A Hunter; Martina Jahn; Dieter Jahn; Gloria C Ferreira
Journal:  J Biol Chem       Date:  2014-06-11       Impact factor: 5.157

3.  Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.

Authors:  Munmun Maiti; Ling-Jie Gao; Chunsheng Huang; Roger G Ptak; Michael G Murray; Steven De Jonghe; Piet Herdewijn
Journal:  Org Biomol Chem       Date:  2016-09-21       Impact factor: 3.876

4.  Impact of the Histidine-Triazole and Tryptophan-Pyrene Exchange in the WHW Peptide: Cu(II) Binding, DNA/RNA Interactions and Bioactivity.

Authors:  Ivona Krošl; Marta Košćak; Karla Ribičić; Biserka Žinić; Dragomira Majhen; Ksenija Božinović; Ivo Piantanida
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

5.  Biodegradable shape memory polymer foams with appropriate thermal properties for hemostatic applications.

Authors:  Lindy K Jang; Grace K Fletcher; Mary Beth B Monroe; Duncan J Maitland
Journal:  J Biomed Mater Res A       Date:  2020-02-21       Impact factor: 4.396

6.  The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.

Authors:  Paula Ossowicz; Joanna Klebeko; Ewa Janus; Anna Nowak; Wiktoria Duchnik; Łukasz Kucharski; Adam Klimowicz
Journal:  RSC Adv       Date:  2020-11-16       Impact factor: 4.036

7.  Absolute Configuration of the New 3-epi-cladocroic Acid from the Mediterranean Sponge Haliclona fulva.

Authors:  Grégory Genta-Jouve; Olivier P Thomas
Journal:  Metabolites       Date:  2013-01-14

8.  Versatile synthesis of the signaling peptide glorin.

Authors:  Robert Barnett; Daniel Raszkowski; Thomas Winckler; Pierre Stallforth
Journal:  Beilstein J Org Chem       Date:  2017-02-08       Impact factor: 2.883

Review 9.  A Compendium of the Most Promising Synthesized Organic Compounds against Several Fusarium oxysporum Species: Synthesis, Antifungal Activity, and Perspectives.

Authors:  Paola Borrego-Muñoz; Felipe Ospina; Diego Quiroga
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

10.  Development of a novel fluorophore for real-time biomonitoring system.

Authors:  Hyun-Ok Song; Binna Lee; Ram Prasad Bhusal; Byounghun Park; Kyoungsik Yu; Chom-Kyu Chong; PyoYun Cho; Sung Yeon Kim; Hak Sung Kim; Hyun Park
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.